FDA Approved: GANCICLOVIR — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ganciclovir from Endo USA, Inc., indicating an approved change to the product under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Cytomegalovirus Retinitis

Drugs mentioned

• GANCICLOVIR (GANCICLOVIR SODIUM)

Snippet

SUPPL AP for GANCICLOVIR (GANCICLOVIR)